Zepp Health Past Earnings Performance
Past criteria checks 0/6
Zepp Health's earnings have been declining at an average annual rate of -63.3%, while the Electronic industry saw earnings growing at 15.4% annually. Revenues have been declining at an average rate of 10.3% per year.
Key information
-63.3%
Earnings growth rate
-63.9%
EPS growth rate
Electronic Industry Growth | 15.3% |
Revenue growth rate | -10.3% |
Return on equity | -7.5% |
Net Margin | -8.5% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Apr 17Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Dec 23Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales
Nov 24Can Zepp Health Find Its Way Back Up?
Jul 31Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M
Aug 25What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Aug 12Zepp: Speculative, But With Potentially Great Rewards
Jun 08What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Mar 16Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value?
Feb 23Zepp Health Stuck In Rut As Global Chip Shortage, Covid Weigh
Jan 06When Should You Buy Zepp Health Corporation (NYSE:ZEPP)?
Dec 15Investors Will Want Zepp Health's (NYSE:ZEPP) Growth In ROCE To Persist
Oct 28Globally Minded Zepp Raises Eyebrows With New Ultra-Long Life Smartwatch
Oct 15Zepp: A Solid International Diversification Play
Oct 03Is It Too Late To Consider Buying Zepp Health Corporation (NYSE:ZEPP)?
Sep 13Zepp Health: Taking Over The Smart Health Wearables Market
Jul 14We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt
Jul 07Returns On Capital Are Showing Encouraging Signs At Zepp Health (NYSE:ZEPP)
May 31Zepp Health Boosts R&D To Minimize Reliance On Xiaomi, Remains A Good Bet
May 08Zepp Or Huami? Wearable Device Maker In China-U.S. Identity Crisis
Apr 26What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Apr 08We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt
Mar 18What We Make Of Huami's (NYSE:HMI) Returns On Capital
Feb 19Revenue & Expenses Breakdown
How Zepp Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 2,137 | -181 | 490 | 340 |
31 Dec 23 | 2,495 | -212 | 503 | 362 |
30 Sep 23 | 2,967 | -279 | 559 | 396 |
30 Jun 23 | 3,571 | -299 | 617 | 449 |
31 Mar 23 | 4,031 | -336 | 671 | 489 |
31 Dec 22 | 4,143 | -288 | 696 | 517 |
30 Sep 22 | 4,733 | -176 | 735 | 497 |
30 Jun 22 | 5,133 | -110 | 711 | 478 |
31 Mar 22 | 5,860 | 90 | 702 | 509 |
31 Dec 21 | 6,250 | 138 | 697 | 515 |
30 Sep 21 | 6,561 | 217 | 661 | 551 |
30 Jun 21 | 7,190 | 248 | 715 | 615 |
31 Mar 21 | 6,492 | 169 | 671 | 572 |
31 Dec 20 | 6,433 | 229 | 620 | 538 |
30 Sep 20 | 6,572 | 320 | 584 | 549 |
30 Jun 20 | 6,200 | 442 | 504 | 500 |
31 Mar 20 | 6,101 | 518 | 469 | 477 |
31 Dec 19 | 5,812 | 573 | 430 | 431 |
30 Sep 19 | 4,925 | 480 | 378 | 376 |
30 Jun 19 | 4,138 | 391 | 352 | 311 |
31 Mar 19 | 3,859 | 387 | 314 | 262 |
31 Dec 18 | 3,645 | 113 | 311 | 263 |
30 Sep 18 | 3,173 | 25 | 265 | 223 |
30 Jun 18 | 2,573 | -69 | 202 | 199 |
31 Mar 18 | 2,304 | -139 | 184 | 187 |
31 Dec 17 | 2,049 | 46 | 159 | 154 |
30 Sep 17 | 1,909 | 54 | 159 | 143 |
31 Dec 16 | 1,556 | -12 | 130 | 132 |
31 Dec 15 | 896 | -61 | 89 | 62 |
Quality Earnings: ZEPP is currently unprofitable.
Growing Profit Margin: ZEPP is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ZEPP is unprofitable, and losses have increased over the past 5 years at a rate of 63.3% per year.
Accelerating Growth: Unable to compare ZEPP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ZEPP is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (-7.6%).
Return on Equity
High ROE: ZEPP has a negative Return on Equity (-7.5%), as it is currently unprofitable.